“…This, coupled with the circumstance that some of the few monoclonal antibodies with broad HIV-1-neutralizing activity recognize epitopes in this region (5,36,40,58), has led others to propose MPER as an interesting target on which to model candidate protective immunogens and antivirals (57). In recent studies, we and others have demonstrated that the MPER of feline immunodeficiency virus (FIV), a naturally occurring lentivirus (41) intensively studied as a model system with which criteria for antiviral vaccines and drugs development can be tested (10,55), shares important structural and functional features with the corresponding domain of HIV-1 (7,14,16,35,38,47,49,50,52). In addition, short synthetic peptides reproducing the MPER of FIV have been shown to inhibit the infectivity of this virus both in vitro and in vivo as a result of blocking cell entry (15,17).…”